In a study by Gao et al. (2019), HCC patients characterized by TP53 mutations had a dysregulated cell cycle and DNA damage repair pathways, and TP53 was the gene with the highest mutation frequency. The gene discussed is TP53; the disease is hepatocellular carcinoma.